Onderzoeker
Sandrine Marie J Aspeslagh
- Trefwoorden:Geneeskunde
- Disciplines:Andere basiswetenschappen niet elders geclassificeerd
Affiliaties
- Observerende Klinische wetenschappen (Departement)
Lid
Vanaf15 nov 2020 → Heden - Medische Oncologie (Departement)
Lid
Vanaf1 feb 2019 → Heden
Publicaties
1 - 10 of 38 results
- Bilateral Corneal Perforation in a Patient Under Anti-PD1 Therapy(2021)
Auteurs: Anaïs Ramaekers, S Aspeslagh, Nele De Brucker, Camille Van Mierlo, Marcel Ten Tusscher, Pieter-Paul Schauwvlieghe, Karolien Termote
Pagina's: 245-247Aantal pagina's: 3 - Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma(2021)
Auteurs: Bastiaan Sol, Jeroen De Filette, Gil Awada, Steven Raeymaeckers, Sandrine Marie J Aspeslagh, Corina Andreescu, Bart Neyns, Brigitte Velkeniers-Hoebanckx
Pagina's: K1-K5Aantal pagina's: 5 - Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19(2020)
Auteurs: Evandro de Azambuja, Mariana Brandão, Hans Wildiers, Annouschka Laenen, Sandrine Marie J Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, et al.
Aantal pagina's: 11 - An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma(2020)
Auteurs: Stijn De Keukeleire, Julia Katharina Schwarze, Gil Awada, Hendrik Everaert, Anne-Marie Vanbinst, Louise Cras, Bart Neyns, Sandrine Marie J Aspeslagh
Pagina's: 524-527Aantal pagina's: 4 - Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study(2019)
Auteurs: Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, et al.
- Immune checkpoint inhibitors and type 1 diabetes mellitus(2019)
Auteurs: Jeroen De Filette, Joeri Pen, Lore Decoster, Thomas Vissers, Bert Bravenboer, Bart Van Der Auwera, Frans K Gorus, Bart O Roep, S Aspeslagh, Bart Neyns, et al.
Pagina's: 363-374Aantal pagina's: 12 - How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?(2019)
Auteurs: Luís Castelo-Branco, Sandrine Aspeslagh, Nuria Kotecki, Ahmad Awada
Pagina's: 420-423Aantal pagina's: 4 - PRIMMO study protocol(2019)
Auteurs: Sandra Tuyaerts, An Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Emiel De Jaeghere, Frédéric Amant, et al.
- Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation(2019)
Auteurs: Marie-Léa Gauci, Emilie Lanoy, Stéphane Champiat, Caroline Caramella, Samy Ammari, Sandrine Aspeslagh, Andrea Varga, Capucine Baldini, Rastilav Bahleda, Anas Gazzah, et al.
Pagina's: 946-956Aantal pagina's: 11 - Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma(2018)
Auteurs: Astrid De Meulenaere, Tijl Vermassen, David Creytens, Sandrine Aspeslagh, Philippe Deron, Frederic Duprez, Sylvie Rottey, Jo A Van Dorpe, Liesbeth Ferdinande
Pagina's: 500-509Aantal pagina's: 10